Myriad Genetics | MYGN - Assets

Stock Price
5.33
Daily Change
-0.01 -0.19%
Monthly
-13.19%
Yearly
-58.78%
Q1 Forecast
5.45

Myriad Genetics reported $728.1M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Agilent USD 12.73B 501M Sep/2025
Becton, Dickinson and Co. USD 55.32B 423M Sep/2025
Bio-Rad Laboratories USD 9.7B 517.7M Sep/2025
Bruker USD 6.43B 95.1M Sep/2025
Danaher USD 83.46B 3.57B Dec/2025
Exact Sciences USD 5.9B 102.64M Sep/2025
Hologic USD 9.18B 165.8M Dec/2025
Illumina USD 6.18B 90M Sep/2025
J&J USD 192.82B 573M Sep/2025
Mettler Toledo International USD 3.52B 121M Sep/2025
Myriad Genetics USD 728.1M 50.8M Sep/2025
Quest Diagnostics USD 16.2B 228M Sep/2025
Quidel USD 5.68B 704M Sep/2025
Repligen USD 2.92B 22.08M Sep/2025
Revvity USD 12.14B 223.84M Sep/2025
Standard Biotools USD 539.64M 17.32M Sep/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
Veracyte USD 1.37B 23.68M Sep/2025
Waters USD 4.86B 144.49M Sep/2025